Wealthfront Advisers
LH icon

Wealthfront Advisers’s Labcorp LH Stock Holding History

Wealthfront Advisers’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.37M Buy
8,894
+1,370
+18% +$371K 0.01% 573
2025
Q4 		$1.89M Buy
7,524
+107
+1% +$28.4K ﹤0.01% 604
2025
Q3 		$2.13M Buy
7,417
+167
+2% +$44.7K 0.01% 574
2025
Q2 		$1.9M Buy
7,250
+685
+10% +$167K ﹤0.01% 583
2025
Q1 		$1.53M Buy
6,565
+114
+2% +$27.7K ﹤0.01% 590
2024
Q4 		$1.48M Buy
6,451
+64
+1% +$14.7K ﹤0.01% 593
2024
Q3 		$1.43M Sell
6,387
-859
-12% -$189K ﹤0.01% 573
2024
Q2 		$1.47M Buy
7,246
+2,289
+46% +$466K 0.01% 549
2024
Q1 		$1.08M Sell
4,957
-614
-11% -$135K ﹤0.01% 599
2023
Q4 		$1.27M Buy
5,571
+1,057
+23% +$222K ﹤0.01% 553
2023
Q3 		$908K Sell
4,514
-1,042
-19% -$220K ﹤0.01% 578
2023
Q2 		$1.15M Sell
5,556
-2,998
-35% -$582K ﹤0.01% 529
2023
Q1 		$1.69M Sell
8,554
-3,793
-31% -$781K 0.01% 443
2022
Q4 		$2.5M Sell
12,347
-2,658
-18% -$519K 0.01% 349
2022
Q3 		$2.64M Buy
15,005
+3,375
+29% +$691K 0.01% 306
2022
Q2 		$2.34M Buy
11,630
+6,619
+132% +$1.41M 0.01% 340
2022
Q1 		$1.14M Sell
5,011
-5,102
-50% -$1.2M 0.01% 503
2021
Q4 		$2.73M Buy
10,113
+572
+6% +$142K 0.01% 324
2021
Q3 		$2.31M Buy
9,541
+6,245
+189% +$1.57M 0.01% 320
2021
Q2 		$781K Buy
3,296
+648
+24% +$148K ﹤0.01% 461
2021
Q1 		$580K Buy
2,648
+343
+15% +$68.8K ﹤0.01% 441
2020
Q4 		$403K Buy
2,305
+61
+3% +$10.5K ﹤0.01% 465
2020
Q3 		$363K Buy
2,244
+85
+4% +$13.5K ﹤0.01% 446
2020
Q2 		$308K Buy
+2,159
New +$299K ﹤0.01% 449
2020
Q1 		– Sell
-2,393
Closed -$348K – 472
2019
Q4 		$348K Buy
2,393
+2
+0.1% +$289 ﹤0.01% 437
2019
Q3 		$345K Buy
2,391
+72
+3% +$10.5K ﹤0.01% 415
2019
Q2 		$344K Buy
2,319
+223
+11% +$31.1K ﹤0.01% 422
2019
Q1 		$276K Buy
+2,096
New +$258K ﹤0.01% 433

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wealthfront Advisers's LH Position: Q1 2026 in Review

Wealthfront Advisers increased its Labcorp (LH) stake by 18% in Q1 2026, buying an estimated $371K and bringing the position to 8,894 shares worth $2.37M. The position accounts for 0.01% of the portfolio, ranked #573.

Wealthfront Advisers first reported a position in LH in Q1 2019 and has held it in 28 quarters since. The position peaked at $2.73M in Q4 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Wealthfront Advisers held 8,894 shares of Labcorp worth $2.37M as of Q1 2026.
  • Wealthfront Advisers bought 1,370 Labcorp shares in Q1 2026, an estimated $371K.
  • Labcorp made up 0.01% of Wealthfront Advisers's portfolio in Q1 2026, its #573 holding.
  • Wealthfront Advisers first reported a position in Labcorp in Q1 2019 and has held it in 28 quarters since.
  • Wealthfront Advisers's Labcorp position peaked at $2.73M in Q4 2021.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Wealthfront Advisers's 13F filing for Q1 2026, filed 5 May 2026.